Tag Archives: fluoroquinolones
January 28th, 2016
A judge has rejected a motion by Johnson & Johnson to dismiss a lawsuit filed against the company by an …
Tags: fluoroquinolones, FQ antibiotics, Johnson & Johnson, Levaquin
Posted in Fluoroquinolones, HO&P Legal Blog |
January 12th, 2016
Peripheral neuropathy is a type of nerve damage affecting the peripheral nerves of the body. Peripheral neuropathy usually affects the …
Tags: Avelox, Cipro, ciprofloxacin, Factive, FDA, Floxin, fluoroquinolones, FQ antibiotics, gemifloxacin, Levaquin, levofloxacin, moxifloxacin, nerve damage, norfloxacin, Noroxin, ofloxacin, peripheral neuropathy
Posted in Fluoroquinolones, HO&P Legal Blog |
September 21st, 2015
A lawsuit filed in Pennsylvania accuses drugmaker Bayer of promoting its antibiotic Cipro for the treatment of bronchitis and other …
Tags: Bayer, Cipro, FDA, fluoroquinolones, FQ antibiotics, nerve damage, peripheral neuropathy
Posted in Fluoroquinolones, HO&P Legal Blog |
September 17th, 2015
Fluoroquinolones—also known as FQ antibiotics or FQs—are a class of antibiotics drugs used to treat certain kinds of bacterial infections, …
Tags: antibiotics, Avelox, Cipro, ciprofloxacin, Factive, Floxin, fluoroquinolones, gemifloxacin, Levaquin, levofloxacin, moxifloxacin, nerve damage, norfloxacin, Noroxin, ofloxacin, peripheral neuropathy
Posted in Fluoroquinolones, HO&P Legal Blog |
August 4th, 2015
Janssen Pharmaceuticals and distributor McKesson Corp. are facing a lawsuit filed by a Texas woman who suffered nerve damage after …
Tags: Avelox, Cipro, ciprofloxacin, Factive, Floxin, fluoroquinolones, FQ antibiotics, gemifloxacin, Levaquin, moxifloxacin, nerve damage, norfloxacin, Noroxin, ofloxacin, peripheral neuropathy
Posted in Fluoroquinolones, HO&P Legal Blog |
March 11th, 2015
A new study published by the American Academy of Neurology has found that patients who begin treatment with a popular …
Tags: Avelox, Cipro, fluoroquinolones, FQ antibiotics, Levaquin, nerve damage, peripheral neuropathy
Posted in Fluoroquinolones, HO&P Legal Blog |